The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

Saturday 28 September 2013
Target Ovarian Cancer welcomes today’s announcement by David Cameron that the Cancer Drugs Fund (CDF) will be extended to 2016 thus giving women in England access to the drug Avastin. However, women with ovarian cancer urgently need clarity on access to vital drugs from 2016 onwards. The aim of the...
Tuesday 25 June 2013
Today NICE announced its Familial Breast Cancer (update) clinical guideline for use in the NHS in England, Wales and Northern Ireland. Target Ovarian Cancer today expressed its disappointment, that despite making its views known on draft guidance in the formal consultation process, NICE have missed...
Thursday 6 June 2013
MPs heard yesterday about fears over the future funding of Avastin in England, and the challenges facing women around the UK in terms of accessing the drug, given recent negative decisions by both the National Institute of Health and Care Excellence (NICE) and the Scottish Medicines Consortium (SMC...
Wednesday 22 May 2013
In two separate pieces of final guidance, the National Institute for Health and Care Excellence (NICE) has advised the NHS against funding the drug bevacizumab (Avastin) for advanced ovarian cancer. Frances Reid, our Director of Public Affairs and Communications at Target Ovarian Cancer said: "The...